Not Signed In - Drug Used In Coronary Artery Bypass Graft Surgery May Increase Risk Of Death
Thu, 08 Feb 2007 04:00 AM EST
... Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the Feb. 7 issue of JAMA. ...
Related Topics
- Coronary Artery Bypass Graft
- Coronary Artery Disease
- Coronary Artery Diseases
- Coronary Disease
- Heart Bypass Surgery
- Coronary Heart Disease
- Weight Loss Surgery
- Risk Factors
- Angioplasty
- Surgery
- Atherosclerosis
- Complications
- Coronary Artery
- Coronary Occlusion
- Coronary artery spasm
- Coronary artery fistula
- Anomalous left coronary artery
- Coronary artery disease (from diabetes and high cholesterol)
- Births, Deaths & Marriages
- Coronary Angioplasty
email this page
print this page
bookmark this page
feedback on this page
